Recalls / Generics / Dobutamine
Dobutamine
2 FDA drug recalls involving generic “Dobutamine” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-05-28 | Class II | DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, | Pfizer Inc. |
| 2014-01-10 | Class I | DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira | Hospira Inc. |